ID   PCNA_RAT                Reviewed;         261 AA.
AC   P04961;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   13-AUG-1987, sequence version 1.
DT   02-OCT-2024, entry version 190.
DE   RecName: Full=Proliferating cell nuclear antigen;
DE            Short=PCNA;
DE   AltName: Full=Cyclin;
GN   Name=Pcna;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar Furth;
RX   PubMed=2884104; DOI=10.1002/j.1460-2075.1987.tb04802.x;
RA   Matsumoto K., Moriuchi T., Koji T., Nakan P.K.;
RT   "Molecular cloning of cDNA coding for rat proliferating cell nuclear
RT   antigen (PCNA)/cyclin.";
RL   EMBO J. 6:637-642(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pituitary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   INTERACTION WITH KCTD10.
RC   STRAIN=Wistar;
RX   PubMed=15982757; DOI=10.1016/j.bbaexp.2005.05.005;
RA   Zhou J., Ren K., Liu X., Xiong X., Hu X., Zhang J.;
RT   "A novel PDIP1-related protein, KCTD10, that interacts with proliferating
RT   cell nuclear antigen and DNA polymerase delta.";
RL   Biochim. Biophys. Acta 1729:200-203(2005).
CC   -!- FUNCTION: Auxiliary protein of DNA polymerase delta and epsilon, is
CC       involved in the control of eukaryotic DNA replication by increasing the
CC       polymerase's processibility during elongation of the leading strand.
CC       Induces a robust stimulatory effect on the 3'-5' exonuclease and 3'-
CC       phosphodiesterase, but not apurinic-apyrimidinic (AP) endonuclease,
CC       APEX2 activities. Has to be loaded onto DNA in order to be able to
CC       stimulate APEX2. Plays a key role in DNA damage response (DDR) by being
CC       conveniently positioned at the replication fork to coordinate DNA
CC       replication with DNA repair and DNA damage tolerance pathways. Acts as
CC       a loading platform to recruit DDR proteins that allow completion of DNA
CC       replication after DNA damage and promote postreplication repair:
CC       Monoubiquitinated PCNA leads to recruitment of translesion (TLS)
CC       polymerases, while 'Lys-63'-linked polyubiquitination of PCNA is
CC       involved in error-free pathway and employs recombination mechanisms to
CC       synthesize across the lesion (By similarity).
CC       {ECO:0000250|UniProtKB:P12004}.
CC   -!- SUBUNIT: Homotrimer. Interacts with p300/EP300; the interaction occurs
CC       on chromatin in UV-irradiated damaged cells. Interacts with CREBBP (via
CC       transactivation domain and C-terminus); the interaction occurs on
CC       chromatin in UV-irradiated damaged cells. Directly interacts with
CC       POLD1, POLD3 and POLD4 subunits of the DNA polymerase delta complex,
CC       POLD3 being the major interacting partner; the interaction with POLD3
CC       is inhibited by CDKN1A/p21(CIP1). Forms a complex with activator 1
CC       heteropentamer in the presence of ATP. Interacts with EXO1, POLH, POLK,
CC       DNMT1, ERCC5, FEN1, CDC6 and POLDIP2. Interacts with POLB (By
CC       similarity). Interacts with APEX2; this interaction is triggered by
CC       reactive oxygen species and increased by misincorporation of uracil in
CC       nuclear DNA. Forms a ternary complex with DNTTIP2 and core histone (By
CC       similarity). Interacts with KCTD10 (PubMed:15982757). Interacts with
CC       PPP1R15A (By similarity). Interacts with SMARCA5/SNF2H (By similarity).
CC       Interacts with BAZ1B/WSTF; the interaction is direct and is required
CC       for BAZ1B/WSTF binding to replication foci during S phase (By
CC       similarity). Interacts with HLTF and SHPRH. Interacts with NUDT15.
CC       Interaction is disrupted in response to UV irradiation and acetylation.
CC       Interacts with CDKN1A/p21(CIP1) and CDT1; interacts via their PIP-box
CC       which also recruits the DCX(DTL) complex. The interaction with CDKN1A
CC       inhibits POLD3 binding. Interacts with DDX11. Interacts with EGFR;
CC       positively regulates PCNA. Interacts with PARPBP. Interacts (when
CC       ubiquitinated) with SPRTN; leading to enhance RAD18-mediated PCNA
CC       ubiquitination. Interacts (when polyubiquitinated) with ZRANB3.
CC       Interacts with SMARCAD1. Interacts with CDKN1C. Interacts with PCLAF
CC       (via PIP-box). Interacts with RTEL1 (via PIP-box); the interaction is
CC       direct and essential for the suppression of telomere fragility.
CC       Interacts with FAM111A (via PIP-box); the interaction is direct and
CC       required for PCNA loading on chromatin binding. Interacts with LIG1.
CC       Interacts with SETMAR. Interacts with ANKRD17. Interacts with
CC       FBXO18/FBH1 (via PIP-box); the interaction recruits the DCX(DTL)
CC       complex and promotes ubiquitination and degradation of FBXO18/FBH1.
CC       Interacts with POLN (By similarity). Interacts with SDE2 (via PIP-box);
CC       the interaction is direct and prevents ultraviolet light induced
CC       monoubiquitination (By similarity). Component of the replisome complex
CC       composed of at least DONSON, MCM2, MCM7, PCNA and TICRR; interaction at
CC       least with PCNA occurs during DNA replication (By similarity).
CC       Interacts with MAPK15; the interaction is chromatin binding dependent
CC       and prevents MDM2-mediated PCNA destruction by inhibiting the
CC       association of PCNA with MDM2. Interacts with PARP10 (via PIP-box) (By
CC       similarity). Interacts with DDI2 (By similarity). Interacts with HMCES
CC       (via PIP-box) (By similarity). Interacts with TRAIP (via PIP-box) (By
CC       similarity). Interacts with UHRF2 (By similarity). Interacts with
CC       ALKBH2; this interaction is enhanced during the S-phase of the cell
CC       cycle. Interacts with ATAD5; the interaction promotes USP1-mediated
CC       PCNA deubiquitination (By similarity). Interacts (when phosphorylated)
CC       with GRB2 (By similarity). {ECO:0000250|UniProtKB:P12004,
CC       ECO:0000250|UniProtKB:P17918, ECO:0000269|PubMed:15982757}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P12004}.
CC       Note=Forms nuclear foci representing sites of ongoing DNA replication
CC       and vary in morphology and number during S phase. Together with APEX2,
CC       is redistributed in discrete nuclear foci in presence of oxidative DNA
CC       damaging agents. Colocalizes with CREBBP, EP300 and POLD1 to sites of
CC       DNA damage (By similarity). {ECO:0000250|UniProtKB:P12004}.
CC   -!- PTM: Phosphorylated. Phosphorylation at Tyr-211 by EGFR stabilizes
CC       chromatin-associated PCNA (By similarity).
CC       {ECO:0000250|UniProtKB:P12004}.
CC   -!- PTM: Acetylated by CREBBP and p300/EP300; preferentially acetylated by
CC       CREBBP on Lys-80, Lys-13 and Lys-14 and on Lys-77 by p300/EP300 upon
CC       loading on chromatin in response to UV irradiation. Lysine acetylation
CC       disrupts association with chromatin, hence promoting PCNA
CC       ubiquitination and proteasomal degradation in response to UV damage in
CC       a CREBBP- and EP300-dependent manner. Acetylation disrupts interaction
CC       with NUDT15 and promotes degradation (By similarity).
CC       {ECO:0000250|UniProtKB:P12004}.
CC   -!- PTM: Ubiquitinated. Following DNA damage, can be either
CC       monoubiquitinated to stimulate direct bypass of DNA lesions by
CC       specialized DNA polymerases or polyubiquitinated to promote
CC       recombination-dependent DNA synthesis across DNA lesions by template
CC       switching mechanisms. Following induction of replication stress,
CC       monoubiquitinated by the UBE2B-RAD18 complex on Lys-164, leading to
CC       recruit translesion (TLS) polymerases, which are able to synthesize
CC       across DNA lesions in a potentially error-prone manner. An error-free
CC       pathway also exists and requires non-canonical polyubiquitination on
CC       Lys-164 through 'Lys-63' linkage of ubiquitin moieties by the E2
CC       complex UBE2N-UBE2V2 and the E3 ligases, HLTF, RNF8 and SHPRH. This
CC       error-free pathway, also known as template switching, employs
CC       recombination mechanisms to synthesize across the lesion, using as a
CC       template the undamaged, newly synthesized strand of the sister
CC       chromatid. Monoubiquitination at Lys-164 also takes place in undamaged
CC       proliferating cells, and is mediated by the DCX(DTL) complex, leading
CC       to enhance PCNA-dependent translesion DNA synthesis. Sumoylated during
CC       S phase (By similarity). {ECO:0000250|UniProtKB:P12004}.
CC   -!- PTM: Methylated on glutamate residues by ARMT1.
CC       {ECO:0000250|UniProtKB:P12004}.
CC   -!- SIMILARITY: Belongs to the PCNA family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y00047; CAA68261.1; -; mRNA.
DR   EMBL; BC060570; AAH60570.1; -; mRNA.
DR   PIR; A26631; WMRTET.
DR   RefSeq; NP_071776.1; NM_022381.3.
DR   AlphaFoldDB; P04961; -.
DR   BMRB; P04961; -.
DR   SMR; P04961; -.
DR   BioGRID; 247765; 8.
DR   ComplexPortal; CPX-542; PCNA homotrimer.
DR   IntAct; P04961; 4.
DR   MINT; P04961; -.
DR   STRING; 10116.ENSRNOP00000028887; -.
DR   PhosphoSitePlus; P04961; -.
DR   jPOST; P04961; -.
DR   PaxDb; 10116-ENSRNOP00000028887; -.
DR   Ensembl; ENSRNOT00000028887.7; ENSRNOP00000028887.4; ENSRNOG00000021264.7.
DR   Ensembl; ENSRNOT00055009473; ENSRNOP00055007288; ENSRNOG00055005861.
DR   Ensembl; ENSRNOT00060003205; ENSRNOP00060002184; ENSRNOG00060002045.
DR   Ensembl; ENSRNOT00065022752; ENSRNOP00065017648; ENSRNOG00065013827.
DR   GeneID; 25737; -.
DR   KEGG; rno:25737; -.
DR   UCSC; RGD:3269; rat.
DR   AGR; RGD:3269; -.
DR   CTD; 5111; -.
DR   RGD; 3269; Pcna.
DR   eggNOG; KOG1636; Eukaryota.
DR   GeneTree; ENSGT00390000004965; -.
DR   HOGENOM; CLU_043978_3_0_1; -.
DR   InParanoid; P04961; -.
DR   OMA; EMKLINM; -.
DR   OrthoDB; 118939at2759; -.
DR   PhylomeDB; P04961; -.
DR   TreeFam; TF313441; -.
DR   Reactome; R-RNO-110312; Translesion synthesis by REV1.
DR   Reactome; R-RNO-110314; Recognition of DNA damage by PCNA-containing replication complex.
DR   Reactome; R-RNO-110320; Translesion Synthesis by POLH.
DR   Reactome; R-RNO-174411; Polymerase switching on the C-strand of the telomere.
DR   Reactome; R-RNO-174414; Processive synthesis on the C-strand of the telomere.
DR   Reactome; R-RNO-174417; Telomere C-strand (Lagging Strand) Synthesis.
DR   Reactome; R-RNO-174437; Removal of the Flap Intermediate from the C-strand.
DR   Reactome; R-RNO-4615885; SUMOylation of DNA replication proteins.
DR   Reactome; R-RNO-5358565; Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha).
DR   Reactome; R-RNO-5651801; PCNA-Dependent Long Patch Base Excision Repair.
DR   Reactome; R-RNO-5655862; Translesion synthesis by POLK.
DR   Reactome; R-RNO-5656121; Translesion synthesis by POLI.
DR   Reactome; R-RNO-5656169; Termination of translesion DNA synthesis.
DR   Reactome; R-RNO-5685942; HDR through Homologous Recombination (HRR).
DR   Reactome; R-RNO-5696397; Gap-filling DNA repair synthesis and ligation in GG-NER.
DR   Reactome; R-RNO-5696400; Dual Incision in GG-NER.
DR   Reactome; R-RNO-6782135; Dual incision in TC-NER.
DR   Reactome; R-RNO-6782210; Gap-filling DNA repair synthesis and ligation in TC-NER.
DR   Reactome; R-RNO-6804114; TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest.
DR   Reactome; R-RNO-69091; Polymerase switching.
DR   Reactome; R-RNO-69166; Removal of the Flap Intermediate.
DR   Reactome; R-RNO-69183; Processive synthesis on the lagging strand.
DR   PRO; PR:P04961; -.
DR   Proteomes; UP000002494; Chromosome 3.
DR   Bgee; ENSRNOG00000021264; Expressed in thymus and 20 other cell types or tissues.
DR   GO; GO:0005813; C:centrosome; ISO:RGD.
DR   GO; GO:0000785; C:chromatin; ISS:UniProtKB.
DR   GO; GO:0000307; C:cyclin-dependent protein kinase holoenzyme complex; ISO:RGD.
DR   GO; GO:0001673; C:male germ cell nucleus; ISO:RGD.
DR   GO; GO:0016604; C:nuclear body; IEA:Ensembl.
DR   GO; GO:0005652; C:nuclear lamina; ISO:RGD.
DR   GO; GO:0043596; C:nuclear replication fork; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; IDA:ComplexPortal.
DR   GO; GO:0043626; C:PCNA complex; ISS:UniProtKB.
DR   GO; GO:0070557; C:PCNA-p21 complex; ISS:UniProtKB.
DR   GO; GO:0005657; C:replication fork; ISO:RGD.
DR   GO; GO:0003682; F:chromatin binding; ISS:UniProtKB.
DR   GO; GO:0003684; F:damaged DNA binding; ISS:UniProtKB.
DR   GO; GO:0032139; F:dinucleotide insertion or deletion binding; ISO:RGD.
DR   GO; GO:0070182; F:DNA polymerase binding; ISO:RGD.
DR   GO; GO:0030337; F:DNA polymerase processivity factor activity; IBA:GO_Central.
DR   GO; GO:0019899; F:enzyme binding; ISO:RGD.
DR   GO; GO:0035035; F:histone acetyltransferase binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0032405; F:MutLalpha complex binding; ISO:RGD.
DR   GO; GO:0030331; F:nuclear estrogen receptor binding; IPI:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; ISO:RGD.
DR   GO; GO:0000701; F:purine-specific mismatch base pair DNA N-glycosylase activity; ISO:RGD.
DR   GO; GO:0030971; F:receptor tyrosine kinase binding; ISO:RGD.
DR   GO; GO:0006287; P:base-excision repair, gap-filling; ISO:RGD.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IEP:RGD.
DR   GO; GO:0034644; P:cellular response to UV; IEP:RGD.
DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; ISO:RGD.
DR   GO; GO:0030855; P:epithelial cell differentiation; ISO:RGD.
DR   GO; GO:0044849; P:estrous cycle; IEP:RGD.
DR   GO; GO:0007507; P:heart development; IEP:RGD.
DR   GO; GO:0006272; P:leading strand elongation; IBA:GO_Central.
DR   GO; GO:0097421; P:liver regeneration; IEP:RGD.
DR   GO; GO:0006298; P:mismatch repair; ISO:RGD.
DR   GO; GO:1902990; P:mitotic telomere maintenance via semi-conservative replication; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0032077; P:positive regulation of deoxyribonuclease activity; ISS:UniProtKB.
DR   GO; GO:0045739; P:positive regulation of DNA repair; ISS:UniProtKB.
DR   GO; GO:0045740; P:positive regulation of DNA replication; ISS:UniProtKB.
DR   GO; GO:0031297; P:replication fork processing; ISO:RGD.
DR   GO; GO:0046686; P:response to cadmium ion; IEP:RGD.
DR   GO; GO:0071548; P:response to dexamethasone; IEP:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:1902065; P:response to L-glutamate; IEP:RGD.
DR   GO; GO:0033993; P:response to lipid; IDA:RGD.
DR   GO; GO:0006979; P:response to oxidative stress; IEP:RGD.
DR   GO; GO:0019985; P:translesion synthesis; ISS:UniProtKB.
DR   CDD; cd00577; PCNA; 1.
DR   Gene3D; 3.70.10.10; -; 1.
DR   HAMAP; MF_00317; DNApol_clamp_arch; 1.
DR   InterPro; IPR046938; DNA_clamp_sf.
DR   InterPro; IPR000730; Pr_cel_nuc_antig.
DR   InterPro; IPR022649; Pr_cel_nuc_antig_C.
DR   InterPro; IPR022659; Pr_cel_nuc_antig_CS.
DR   InterPro; IPR022648; Pr_cel_nuc_antig_N.
DR   NCBIfam; TIGR00590; pcna; 1.
DR   PANTHER; PTHR11352; PROLIFERATING CELL NUCLEAR ANTIGEN; 1.
DR   PANTHER; PTHR11352:SF0; PROLIFERATING CELL NUCLEAR ANTIGEN; 1.
DR   Pfam; PF02747; PCNA_C; 1.
DR   Pfam; PF00705; PCNA_N; 1.
DR   PRINTS; PR00339; PCNACYCLIN.
DR   SUPFAM; SSF55979; DNA clamp; 2.
DR   PROSITE; PS01251; PCNA_1; 1.
DR   PROSITE; PS00293; PCNA_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; DNA damage; DNA repair; DNA replication; DNA-binding;
KW   Isopeptide bond; Methylation; Nucleus; Phosphoprotein; Reference proteome;
KW   Ubl conjugation.
FT   CHAIN           1..261
FT                   /note="Proliferating cell nuclear antigen"
FT                   /id="PRO_0000149161"
FT   DNA_BIND        61..80
FT                   /evidence="ECO:0000255"
FT   MOD_RES         14
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P12004"
FT   MOD_RES         77
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P12004"
FT   MOD_RES         80
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P12004"
FT   MOD_RES         211
FT                   /note="Phosphotyrosine; by EGFR"
FT                   /evidence="ECO:0000250|UniProtKB:P12004"
FT   MOD_RES         248
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P12004"
FT   CROSSLNK        164
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P12004"
FT   CROSSLNK        164
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P12004"
FT   CROSSLNK        254
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P12004"
SQ   SEQUENCE   261 AA;  28749 MW;  CE55E9BA46C50F07 CRC64;
     MFEARLIQGS ILKKVLEALK DLINEACWDI SSGGVNLQSM DSSHVSLVQL TLRSEGFDTY
     RCDRNLAMGV NLTSMSKILK CAGNEDIITL RAEDNADTLA LVFEAPNQEK VSDYEMKLMD
     LDVEQLGIPE QEYSCVVKMP SGEFARICRD LSHIGDAVVI SCAKDGVKFS ASGELGNGNI
     KLSQTSNVDK EEEAVSIEMN EPVQLTFALR YLNFFTKATP LSPTVTLSMS ADVPLVVEYK
     IADMGHLKYY LAPKIEDEEG S
//
